Evidence map›Paper›PMID 30546363›Full record

ArticleFrontiers in immunology2018

Nivea F Luz, Thiago DeSouza-Vieira, Waldione De Castro, Aislan Carvalho Vivarini, Lais Pereira, Riam Rocha França, Paulo S Silveira-Mattos, Diego L Costa, Clarissa Teixeira, Claudio Meneses and 9 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. The Potential Role of Nrf2 Signaling in Leishmania Infection Outcomes.Frontiers in cellular and infection microbiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Nivea F LuzGonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
Thiago DeSouza-VieiraVector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States.
Waldione De CastroVector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States.
Aislan Carvalho VivariniLaboratory of Molecular Parasitology, Center of Health Science, Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Lais PereiraVector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States.
Riam Rocha FrançaGonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
Paulo S Silveira-MattosGonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
Diego L CostaImmunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Clarissa TeixeiraOswaldo Cruz Foundation (Fiocruz-PI), Teresina, Brazil.
Claudio MenesesVector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States.
Viviane S BoaventuraGonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
Camila I de OliveiraGonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
Ulisses Gazos LopesLaboratory of Molecular Parasitology, Center of Health Science, Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Naomi AronsonInfectious Diseases Division, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
Bruno B AndradeGonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
Claudia I BrodskynGonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
Jesus G ValenzuelaVector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States.
Shaden KamhawiVector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States.
Valeria M BorgesGonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
Fundação Oswaldo Cruz · BRVector (United States) · USUniversidade Federal da Bahia · BRNational Institute of Allergy and Infectious Diseases · USUniversidade Federal do Rio de Janeiro · BRNational Institutes of Health · USUniformed Services University of the Health Sciences · US

Funding

Molecular approaches to understand vector-host and vector-pathogen interactionsZIAAI000932 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI VALENZUELA, JESUS · 2009 to 2025
$23.1M
6 · The paper itself

Abstract

Sand flies bite mammalian hosts to obtain a blood meal, driving changes in the host inflammatory response that support the establishment of

Indexed as

Gene Expression Regulation, EnzymologicInsect VectorsPsychodidaeSalivaAnimalsFemaleHeme Oxygenase-1HumansInsect Bites and StingsLeishmaniaMaleMembrane ProteinsMiceMice, KnockoutRAW 264.7 CellsSkinHeme Oxygenase-1HMOX1 protein, humanHmox1 protein, mouseMembrane Proteinsheme oxygenase-1Lutzomyia longipalpismacrophagesNrf2salivasand fly biteskin

Identifiers

PMID30546363
PMCPMC6279893
OpenAlexW2902986921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.